|
|
||||||||
1 Department of Radiology, Division of Neuroradiology, The Johns Hopkins
University School of Medicine, 600 N. Wolfe St., Baltimore, MD
21287-2182.
2 Department of Radiology, Brooke Army Medical Center, 3851 Roger Brooke Dr.,
Fort Sam Houston, TX 78234-3600.
3 Department of Radiology, Brigham and Women's Hospital, 75 Francis St., Boston,
MA 02115.
4 United States Food and Drug Administration, 5600 Fishers Ln., Rockville, MD
20857.
5 Department of Radiology, Division of Neuroradiology, Hospital of the
University of Pennsylvania, 3400 Sruce St., Philadelphia, PA 19104.
6 Guilford Pharmaceuticals, 6611 Tributary St., Baltimore, MD 21224.
7 Department of Neurosurgery, The Johns Hopkins University School of Medicine,
Baltimore, MD 21287.
OBJECTIVE. The objective of our study was to describe the CT and MR imaging appearances of the surgical bed in the brains of patients receiving biodegradable polymers impregnated with N, N'1, 3-Bis-(2-chloroethyl)-N-nitrosourea (BCNU) for recurrent glioma and to determine whether patients receiving placebos could be differentiated from those receiving BCNU based on the pattern and growth kinetics of tumor recurrence.
MATERIALS AND METHODS. The CT and MR images of 20 patients who underwent surgery for resection of recurrent high-grade gliomas and placement of intratumoral wafers (11 received BCNU polymer wafers, nine received control wafers) were analyzed for wafer appearance, volume of gas in the tumor bed, and volume of enhancement on serial scans.
RESULTS. Wafers appeared as linear hyperdense structures on CT and as linear low-signal-intensity structures on MR imaging and caused no significant enhancement. In the BCNU polymer group, gas volume was 4.0 ± 3.4 cm3 (mean ± SD), whereas gas volume was 1.6 ± 3.0 cm3 for the placebo group (Mann-Whitney test, p = 0.03). A trend toward linear rather than exponential recurrent tumor growth was identified for the BCNU polymer group but not for the placebo group.
CONCLUSION. BCNU polymer wafers have a specific appearance on CT and MR imaging with which radiologists should be familiar: gas in the surgical bed is an expected transient finding, and tumor regrowth in patients receiving BCNU polymer wafers appeared to occur at a slower rate than in those receiving the placebo.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. B. Hunter, M. T. Yoshino, R. B. Dzioba, R. A. Light, and W. G. Berger Medical Devices of the Head, Neck, and Spine RadioGraphics, January 1, 2004; 24(1): 257 - 285. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |